![](/sites/default/files/styles/vertical_teaser/public/2019-01/cimzia-and-you.png?itok=atgrPt-I)
![](/sites/default/files/styles/vertical_teaser/public/2019-01/patients-journey-1.png?itok=0MBqgyZD)
![UCBCares](/sites/default/files/styles/vertical_teaser/public/2019-01/Nurse-edited.png?itok=O3-ftkRl)
PrCIMZIA® (certolizumab pegol) in combination with methotreaxate (MTX) is indicated for:
PrCIMZIA® may be used alone for reducing signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis (RA) who do not tolerate MTX.
PrCIMZIA® alone or in combination with methotrexate (MTX) is indicated for:
PrCIMZIA® is indicated for:
PrCIMZIA® is indicated for:
If you have any questions, please contact the: UCBCares™ call-centre at 1-800-908-5555.
The call centre is available from 8am to 8pm. Nurse case managers are available from 9am to 5pm EST.